BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 15669895)

  • 1. Incidence of sexual side effects in refractory depression during treatment with citalopram or paroxetine.
    Landén M; Högberg P; Thase ME
    J Clin Psychiatry; 2005 Jan; 66(1):100-6. PubMed ID: 15669895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of buspirone on sexual dysfunction in depressed patients treated with selective serotonin reuptake inhibitors.
    Landén M; Eriksson E; Agren H; Fahlén T
    J Clin Psychopharmacol; 1999 Jun; 19(3):268-71. PubMed ID: 10350034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, double-blind, placebo-controlled trial of buspirone in combination with an SSRI in patients with treatment-refractory depression.
    Landén M; Björling G; Agren H; Fahlén T
    J Clin Psychiatry; 1998 Dec; 59(12):664-8. PubMed ID: 9921700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Vortioxetine vs. Escitalopram on Sexual Functioning in Adults with Well-Treated Major Depressive Disorder Experiencing SSRI-Induced Sexual Dysfunction.
    Jacobsen PL; Mahableshwarkar AR; Chen Y; Chrones L; Clayton AH
    J Sex Med; 2015 Oct; 12(10):2036-48. PubMed ID: 26331383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients with severe depression may benefit from buspirone augmentation of selective serotonin reuptake inhibitors: results from a placebo-controlled, randomized, double-blind, placebo wash-in study.
    Appelberg BG; Syvälahti EK; Koskinen TE; Mehtonen OP; Muhonen TT; Naukkarinen HH
    J Clin Psychiatry; 2001 Jun; 62(6):448-52. PubMed ID: 11465522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sexual functioning assessed in 4 double-blind placebo- and paroxetine-controlled trials of duloxetine for major depressive disorder.
    Delgado PL; Brannan SK; Mallinckrodt CH; Tran PV; McNamara RK; Wang F; Watkin JG; Detke MJ
    J Clin Psychiatry; 2005 Jun; 66(6):686-92. PubMed ID: 15960560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidepressant-induced sexual dysfunction during treatment with moclobemide, paroxetine, sertraline, and venlafaxine.
    Kennedy SH; Eisfeld BS; Dickens SE; Bacchiochi JR; Bagby RM
    J Clin Psychiatry; 2000 Apr; 61(4):276-81. PubMed ID: 10830148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies.
    Clayton AH; Croft HA; Horrigan JP; Wightman DS; Krishen A; Richard NE; Modell JG
    J Clin Psychiatry; 2006 May; 67(5):736-46. PubMed ID: 16841623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical implications of directly switching antidepressants in well-treated depressed patients with treatment-emergent sexual dysfunction: a comparison between vortioxetine and escitalopram.
    Jacobsen PL; Nomikos GG; Zhong W; Cutler AJ; Affinito J; Clayton A
    CNS Spectr; 2020 Feb; 25(1):50-63. PubMed ID: 31010445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Switching Selective Serotonin Reuptake Inhibitors in Adolescents with Selective Serotonin Reuptake Inhibitor-Resistant Major Depressive Disorder: Balancing Tolerability and Efficacy.
    Strawn JR; Mills JA; Croarkin PE
    J Child Adolesc Psychopharmacol; 2019 May; 29(4):250-255. PubMed ID: 30810350
    [No Abstract]   [Full Text] [Related]  

  • 11. Sexual dysfunction during treatment of major depressive disorder with vilazodone, citalopram, or placebo: results from a phase IV clinical trial.
    Clayton AH; Gommoll C; Chen D; Nunez R; Mathews M
    Int Clin Psychopharmacol; 2015 Jul; 30(4):216-23. PubMed ID: 26039688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in sexual functioning associated with duloxetine, escitalopram, and placebo in the treatment of patients with major depressive disorder.
    Clayton A; Kornstein S; Prakash A; Mallinckrodt C; Wohlreich M
    J Sex Med; 2007 Jul; 4(4 Pt 1):917-29. PubMed ID: 17627739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind, randomized, parallel-group, flexible-dose study to evaluate the tolerability, efficacy and effects of treatment discontinuation with escitalopram and paroxetine in patients with major depressive disorder.
    Baldwin DS; Cooper JA; Huusom AK; Hindmarch I
    Int Clin Psychopharmacol; 2006 May; 21(3):159-69. PubMed ID: 16528138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Selective serotonin reuptake inhibitors in major depressive disorder in children and adolescents (ratio of benefits/risks)].
    Hjalmarsson L; Corcos M; Jeammet P
    Encephale; 2005; 31(3):309-16. PubMed ID: 16142045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response acceleration with mirtazapine augmentation of citalopram in obsessive-compulsive disorder patients without comorbid depression: a pilot study.
    Pallanti S; Quercioli L; Bruscoli M
    J Clin Psychiatry; 2004 Oct; 65(10):1394-9. PubMed ID: 15491244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoactive sexual desire among depressed female patients treated with selective serotonin reuptake inhibitors: a comparison between escitalopram and fluoxetine.
    Sidi H; Asmidar D; Hod R; Jaafar NR; Guan NC
    Int J Psychiatry Clin Pract; 2012 Mar; 16(1):41-7. PubMed ID: 22122658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the onset of antidepressant-induced sexual dysfunction using interactive voice response technology.
    Dunn JA; Arakawa R; Greist JH; Clayton AH
    J Clin Psychiatry; 2007 Apr; 68(4):525-32. PubMed ID: 17474807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.
    Lenox-Smith AJ; Jiang Q
    Int Clin Psychopharmacol; 2008 May; 23(3):113-9. PubMed ID: 18408525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sexual function during bupropion or paroxetine treatment of major depressive disorder.
    Kennedy SH; Fulton KA; Bagby RM; Greene AL; Cohen NL; Rafi-Tari S
    Can J Psychiatry; 2006 Mar; 51(4):234-42. PubMed ID: 16629348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A placebo-controlled, randomized, double-blind study of adjunctive bupropion sustained release in the treatment of SSRI-induced sexual dysfunction.
    DeBattista C; Solvason B; Poirier J; Kendrick E; Loraas E
    J Clin Psychiatry; 2005 Jul; 66(7):844-8. PubMed ID: 16013899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.